Maria Di Bari Selected Research

Muscarinic M2 Receptor

1/2021	M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines.
5/2018	Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation.
11/2015	The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells.
11/2015	Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells.
1/2014	M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.
4/2013	M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Di Bari Research Topics

Disease

5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2013
5	Multiple Sclerosis 01/2018 - 11/2015
4	Inflammation (Inflammations) 01/2018 - 11/2015
2	Neuroinflammatory Diseases 01/2018 - 01/2017
2	Neoplasms (Cancer) 11/2015 - 01/2014
1	Peritonitis 02/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018
1	Disease Progression 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014
1	Glioma (Gliomas) 04/2013

Drug/Important Bio-Agent (IBA)

6	Muscarinic M2 ReceptorIBA 01/2021 - 04/2013
5	arecaidineIBA 01/2021 - 04/2013
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2021 - 01/2014
3	EstersIBA 01/2021 - 11/2015
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018 - 11/2015
2	EnzymesIBA 01/2018 - 11/2015
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 01/2017
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017 - 11/2016
2	CytokinesIBA 11/2016 - 11/2015
1	Cholinergic ReceptorsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2018
1	AcetylcholinesteraseIBA 01/2018
1	ButyrylcholinesteraseIBA 01/2018
1	Sirtuin 1IBA 11/2015
1	Nicotine FDA Link 11/2015
1	Superoxide DismutaseIBA 11/2015
1	Cytostatic AgentsIBA 11/2015
1	Histones (Histone)IBA 11/2015
1	Temozolomide (Temodar)FDA LinkGeneric 04/2013

Therapy/Procedure

2	Therapeutics 01/2018 - 04/2013
1	Peritoneal Dialysis 02/2022